MaxCyte

Download MaxCyte Flow Electroporation: Vaccine Research & Development

In the run-up to the World Vaccine Congress, MaxCyte has provided us with this whitepaper on Flow Electroporation and its implications in vaccine research and development.  “MaxCyte’s proprietary flow electroporation is a universal transient transfection technology for rapid, high-quality cell transfection. Flow electroporation enables (co)transfection of a wide range of cells with DNA, RNA, siRNA, proteins, or cell lysates and …

White Paper provided by Virocyt: An Overview of Virus Quantification Techniques

Click here to download the White Paper provided by Virocyt: “An Overview of Virus Quantification Techniques”. Settings in which viruses play a primary role, such as vaccine production, using viruses to express proteins, the development of antiviral drugs, and therapeutic viruses (oncolytic viruses for example), require accurate assessment of viral concentration across the entire product development lifecycle.  Although time-tested, many …

Download: Replikins whitepaper on preventing influenza pandemics, predicting outbreaks and H5N1

Samuel Bogoch, Chairman of Replikins, kindly provided this whitepaper, ‘The possibility of preventing pandemics: Highest Replikin counts in H5N1 HA and p B1 genes in 2010 and 2011 predict specific new variants with increased infectivity and lethality.’ Download the whitepaper here. The whitepaper argues that, “the possibility of preventing the development of influenza virus outbreaks and pandemics is being considered …

Centre de Recherche Clinique Étienne-Le Bel on influenza immunity and virus-host interaction

Martin Richter, Associate Professor, Department of Medicine at Centre de Recherche Clinique Étienne-Le Bel, kindly provided this link to an interesting article, entitled ‘Initial infectious dose dictates the innate, adaptive, and memory responses to influenza in the respiratory tract,’ originally published in the Journal of Leukocyte Biology. View the article on the Journal’s website. Several viral factors contribute to influenza …

Whitepaper available from LabCorp: sponsor of the World Vaccine Congress Lyon 2012

Labcorp Clinical Trials combines standardized international laboratory capabilities with sophisticated diagnostic technologies to provide a broad portfolio of clinical assays to support drug and diagnostic clinical studies. We have four dedicated central lab facilities located in China, Belgium, Singapore, and the United States. Our scientific team, with expertise across major therapeutic areas, provides extensive support for protocol design and custom …

Download: AfriVax whitepaper on next-gen technologies for egg-based biopharmaceutical manufacturing

Eluemuno Blyden, Founder and CEO of AfriVax, kindly provided this whitepaper entitled, ‘Poultry Pharming: Next-Generation Technologies for Egg-Based Biopharmaceutical Manufacturing.’ Download the whitepaper here. Originally published by IEEE, the whitepaper states that “recombinant vector technologies for embryonated hen eggs are an emerging platform for global health applications including production of vaccines and biologics.” It goes on to suggest that “industrializing …

Download: Retroscreen Virology paper on preexisting influenza-specific CD4+ T cells and correlation with disease protection

Retroscreen Virology kindly provided this whitepaper, entitled ‘Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.’ Download the whitepaper here. In the paper, the authors suggest that “protective immunity against influenza virus infection is mediated by neutralizing antibodies, but the precise role of T cells in human influenza immunity is uncertain.” Because of this, they …

Download: EpiVax whitepapers on H1N1 influenza vaccines, T cell epitopes and more!

Dr. Annie DeGroot, Chief Executive Officer and Chief Scientific Officer at EpiVax, Inc., will be speaking at the upcoming Influenza Congress USA on the topic, ‘Genome-to-vaccine development of a broad spectrum influenza vaccine.’ Annie kindly provided these whitepapers, entitled ‘Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4+ T cells against the swine-origin H1N1 influenza virus,’ and …